A detailed history of Geode Capital Management, LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 5,904,999 shares of OCGN stock, worth $6.97 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,904,999
Previous 3,213,520 83.75%
Holding current value
$6.97 Million
Previous $5.27 Million 73.66%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$1.18 - $1.98 $3.18 Million - $5.33 Million
2,691,479 Added 83.75%
5,904,999 $9.15 Million
Q1 2024

May 13, 2024

BUY
$0.5 - $1.83 $141,786 - $518,936
283,572 Added 9.68%
3,213,520 $5.27 Million
Q4 2023

Feb 13, 2024

BUY
$0.36 - $0.57 $24,654 - $39,036
68,485 Added 2.39%
2,929,948 $1.67 Million
Q3 2023

Nov 13, 2023

SELL
$0.4 - $0.62 $602 - $933
-1,505 Reduced 0.05%
2,861,463 $1.14 Million
Q2 2023

Aug 11, 2023

SELL
$0.45 - $0.88 $809,264 - $1.58 Million
-1,798,365 Reduced 38.58%
2,862,968 $1.55 Million
Q1 2023

May 15, 2023

BUY
$0.82 - $1.33 $424,600 - $688,681
517,806 Added 12.5%
4,661,333 $3.96 Million
Q4 2022

Feb 13, 2023

BUY
$1.11 - $1.87 $374,712 - $631,272
337,579 Added 8.87%
4,143,527 $5.39 Million
Q3 2022

Nov 14, 2022

BUY
$1.75 - $3.1 $221,973 - $393,210
126,842 Added 3.45%
3,805,948 $6.77 Million
Q2 2022

Aug 12, 2022

BUY
$1.83 - $3.45 $1.53 Million - $2.88 Million
835,005 Added 29.36%
3,679,106 $8.35 Million
Q1 2022

May 13, 2022

SELL
$2.34 - $4.72 $1.01 Million - $2.03 Million
-430,234 Reduced 13.14%
2,844,101 $9.39 Million
Q4 2021

Feb 11, 2022

SELL
$4.38 - $15.67 $361,266 - $1.29 Million
-82,481 Reduced 2.46%
3,274,335 $14.9 Million
Q3 2021

Nov 12, 2021

BUY
$6.36 - $8.51 $1.11 Million - $1.48 Million
173,982 Added 5.47%
3,356,816 $24.1 Million
Q2 2021

Aug 13, 2021

BUY
$5.52 - $15.68 $8.54 Million - $24.3 Million
1,547,662 Added 94.65%
3,182,834 $25.6 Million
Q1 2021

May 12, 2021

BUY
$1.66 - $15.81 $695,136 - $6.62 Million
418,757 Added 34.43%
1,635,172 $11.1 Million
Q4 2020

Feb 12, 2021

BUY
$0.28 - $2.6 $187,901 - $1.74 Million
671,075 Added 123.06%
1,216,415 $2.23 Million
Q3 2020

Nov 13, 2020

BUY
$0.2 - $0.72 $68,951 - $248,225
344,757 Added 171.88%
545,340 $169,000
Q1 2020

May 14, 2020

BUY
$0.26 - $0.73 $52,151 - $146,425
200,583 New
200,583 $56,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $256M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.